Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03445585 · ClinicalTrials.gov registry record
Biobank for Cholestatic Liver Diseases.
A clinical trial of Liver Cancer and Cholangiocarcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 9,150
- Enrollment target
- 1
- Study location
NCT03445585 is a study of Liver Cancer and Cholangiocarcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 9,150 participants, above the 331-participant average among 78 other Liver Cancer trials with a reported enrollment target (2664% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03445585, a study of Liver Cancer and Cholangiocarcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 9,150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver diseases primary biliary cirrhosis/cholangitis (PBC) and primary sclerosing cholangitis (PSC).
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,150 participants |
| Start Date | 2017-01 |
| Est. Completion | 2050-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03445585
The ClinicalTrials.gov registry entry for NCT03445585 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 9,150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 331-participant average among 78 other Liver Cancer trials with a reported enrollment target (2664% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Liver Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03445585 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03445585 about?
NCT03445585 is a clinical study titled "Biobank for Cholestatic Liver Diseases.". This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver diseases primary biliary cirrhosis/cholangitis (PBC) and primary sclerosing cholangitis (PSC).
What is the current status of trial NCT03445585?
This trial is currently recruiting. The enrollment target is 9,150 participants. The study started on 2017-01. Estimated completion is 2050-01.
What conditions does trial NCT03445585 study?
This clinical trial studies the following conditions: Liver Cancer, Cholangiocarcinoma, Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis.
Who is sponsoring clinical trial NCT03445585?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03445585 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility Study of CBCT for IGRT in Cancer Patients
RECRUITING · NA
-
Collection of Blood From Patients With Cancer
RECRUITING
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
RECRUITING · NA
-
Multi-analyte Blood Test Clinical Trial
RECRUITING
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.